Jane K. Stock

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement

Florian Kronenberg, Samia Mora, Erik S.G. Stroes et al. · European Heart Journal · 2022 · 1.1K citations · Full text

Vascular Disease, Cardiometabolic Risk, Hyperlipidemia +22

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Henry N. Ginsberg, Chris J. Packard, M. John Chapman et al. · European Heart Journal · 2021 · 804 citations · Full text

Vascular Disease, Hyperlipidemia, Triglyceride-rich Lipoproteins +23

2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance

Marina Cuchel, Frederick J. Raal, Robert A. Hegele et al. · European Heart Journal · 2023 · 280 citations · Full text

2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia

Ulf Landmesser, M. John Chapman, Jane K. Stock et al. · European Heart Journal · 2017 · 199 citations · Full text

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society

Jeanine E. Roeters van Lennep, Lâle Tokgözoğlu, Lina Badimón et al. · European Heart Journal · 2023 · 191 citations · Full text

Hypertension, Vascular Disease, Gynecology +19